STUDY ON MADHUMEGAM [TYPE 2 DIABETES MELLITUS] WITH SIDDHA MEDICINE ULOGA CHENDURAM AND OIL BATH ASHWAGANDHATHI THAILAM

A CLINICAL TRIAL ON THERAPEUTIC EFFICACY OF SIDDHA HERBOMINERAL FORMULATION ULOGA CHENDURAM (INTERNAL) AND ASHWAGANDHATHI THAILAM(OIL BATH) FOR NEERIZHIVU(NON-INSULIN DEPENDENT (TYPE II) DIABETES MELLITUS). - Diabetes mellitus (madhumegam)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/10/021833

Enrollment

Registered

2019-10-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

Intervention1: ULOGA CHENDURAM [INTRNAL] ASHWAGANDHATHI THAILAM [OIL BATH]: 488mg, twice a day, internal for 90 days oil bath weekly twice Intervention2: NOT APPLICABLE: NOT APPLICABLE Intervention3:

Eligibility

Inclusion criteria

Inclusion criteria: fasting blood sugar; above 120 mgs/dl post prandial blood sugar; below 300mgs/dl HbA1c 6.5% diagonosed with or without clinical symptoms, polyuria, polydipsia, polyphagia, body pain, nocturia. weight loss, tiredness, burning feet and genital pruritis, subjects who fulfil the above three criteria wioll be included in the clinical trial

Exclusion criteria

Exclusion criteria: Insulin dependent diabetes mellitus Hba1c >10% Thyroid dysfunctions gestational diabetes other endocrine abnormalities existing renal, hepatic, cardiac disease and major illness womens who are planning for pregnancy subjects who are not willing to give informed consent

Design outcomes

Primary

Measure	Time frame
The outcome will be mainly assessed by comparing the before and after treatment value of serum HbA1c levelsTimepoint: 90 days	—

Secondary

Measure	Time frame
secondary outcome will be assessed by comparing the following parameters, pre and post treatment changes in siddha clinical parameters changes in investigation like fasting blood sugar, post prandial blood sugarTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr R Gomathi

Ayodidoss pandithar hospital

drlakshmiramaswamy@gmail.com944466880

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026